Evaxion A/S Logo

Evaxion A/S

A clinical-stage TechBio company developing immunotherapies using an AI platform.

EVAX | US

Overview

Corporate Details

ISIN(s):
US29970R3030
LEI:
Country:
United States of America
Address:
DR NEERGAARDS VEJ 5F, 0 HOERSHOLM

Description

Evaxion A/S is a clinical-stage TechBio company specializing in the development of immunotherapies using its proprietary, clinically validated AI-Immunology™ platform. The platform leverages artificial intelligence and machine learning to decode the human immune system, enabling the rapid discovery and design of novel vaccine targets. Evaxion focuses on creating personalized and precision vaccines for the treatment of cancer and infectious diseases. Its pipeline includes personalized cancer vaccines in clinical development, such as EVX-01 for melanoma, and a preclinical portfolio targeting infectious diseases. The company's technology aims to accelerate the development of tailored vaccine candidates to address critical diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Evaxion A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Evaxion A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Evaxion A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ceres Power Holdings PLC Logo
A developer of solid oxide technology for clean power and green hydrogen production.
United Kingdom
CWR
Certara, Inc. Logo
Accelerates drug development using biosimulation software, technology, and services.
United States of America
CERT
CervoMed Inc. Logo
A clinical-stage biotech developing treatments for age-related neurologic disorders.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and provides CDMO and bio-banking services.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
A CRO providing end-to-end solutions to accelerate oncology drug development.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
A contract research organization supporting drug discovery and development.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech company developing antibody-based therapeutics.
Japan
4583
Chordate Medical Holding AB Logo
Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops and licenses plant traits using non-GMO precision gene-editing technology.
United States of America
CBUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.